✦ LIBER ✦

Leucocyte migration inhibition with armadillo Lepromin in human lymphocytes of healthy donors

✍ Scribed by D. Fumarola; E. Jirillo

Book ID: 105262943
Publisher: Springer-Verlag
Year: 1978
Tongue: English
Weight: 346 KB
Volume: 6
Category: Article
ISSN: 0300-8126
DOI: 10.1007/bf01641082

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of HIV-1 replication by a Tat

Inhibition of HIV-1 replication by a Tat transdominant negative mutant in human peripheral blood lymphocytes from healthy donors and HIV-1-infected patients

✍ Rossi, C; Balboni, P G; Betti, M; Marconi, P C; Bozzini, R; Grossi, M P; Barbant 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 267 KB

Inhibition of lymphocyte blastogenic res

Inhibition of lymphocyte blastogenic response in healthy donors treated with recombinant human granulocyte colony-stimulating factor (rhG-CSF): possible role of lactoferrin and interleukin-1 receptor antagonist

✍ Rutella, S; Rumi, C; Testa, U; Sica, S; Teofili, L; Martucci, R; Peschle, C; Leo 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 225 KB

In vitro studies with “transfer factor”:

In vitro studies with “transfer factor”: II. Transfer of the cell-migration inhibition correlate of delayed hypersensitivity in humans with nondialyzable components of leucocyte lysates from humans sensitized to histoplasmin and coccidioidin

✍ Ronald E. Paque; Sheldon Dray; Peter Kniskern; Peter Baram 📂 Article 📅 1973 🏛 Elsevier Science 🌐 English ⚖ 456 KB

Induction of human tumor-associated diff

Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1–positive healthy donors and patients with advanced ovarian cancer

✍ Stefania Bellone; Simone Anfossi; Timothy J. O'Brien; Martin J. Cannon; Dan-Arin 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 583 KB

## Abstract ## BACKGROUND: Tumor‐associated differentially expressed gene‐12 (TADG‐12) is a serine protease recently found highly differentially expressed in epithelial ovarian cancer. The goal of this study was to identify potential immunogenic peptides derived from TADG‐12 for immunotherapy of o